Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to Canada

The import of blood, antisera, vaccines, toxins, and cultures to Canada is projected to rise steadily from 2024 through 2028, growing from $5.634 billion in 2024 to $6.4634 billion in 2028. The year-on-year growth for each interval is approximately 3.8%, reflecting a consistent upward trend. Considering the sector's performance in 2023, this forecast outlines an expansion trajectory influenced by heightened demand and advancements in biotechnology. This trend demonstrates a healthy sector evolution with a CAGR suggesting robust annual growth over the projection period.

Future trends to watch for include the impact of technological advancements in biotechnology, changes in global health policies, and potential shifts in supply chain dynamics. Also, evolving needs in global health crises management and disease prevention could significantly affect demand patterns.